Published in Can J Cardiol on November 30, 2012
BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure. Heart Fail Rev (2014) 0.96
Epidemiology and aetiology of heart failure. Nat Rev Cardiol (2016) 0.93
Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations. Clin J Am Soc Nephrol (2013) 0.93
Effect of tree nuts on metabolic syndrome criteria: a systematic review and meta-analysis of randomised controlled trials. BMJ Open (2014) 0.92
A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods. Heart Fail Rev (2014) 0.90
Aldosterone antagonists in systolic heart failure. Can Fam Physician (2014) 0.88
Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence. Drugs Aging (2014) 0.85
The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study. BMC Cardiovasc Disord (2014) 0.82
Potential effects of rational prescribing on national health care spending: More than half a billion dollars in annual savings. Can Fam Physician (2016) 0.81
Relationship between lipids levels and right ventricular volume overload in congestive heart failure. J Geriatr Cardiol (2014) 0.79
Performance of BNP and NT-proBNP for diagnosis of heart failure in primary care patients: a systematic review. Heart Fail Rev (2014) 0.78
Thiamin deficiency and heart failure: the current knowledge and gaps in literature. Heart Fail Rev (2015) 0.78
Trial of a family-based education program for heart failure patients in rural Thailand. BMC Cardiovasc Disord (2014) 0.76
Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks. Clin J Am Soc Nephrol (2016) 0.75
Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD. PLoS One (2016) 0.75
Influence of cardiac rehabilitation in Primigravida with spontaneous coronary artery dissection during postpartum. Int Arch Med (2014) 0.75
Clinical value of plasma B-type natriuretic peptide assay in pediatric pneumonia accompanied by heart failure. Exp Ther Med (2015) 0.75
Barriers to goals of care discussions with hospitalized patients with advanced heart failure: feasibility and performance of a novel questionnaire. ESC Heart Fail (2016) 0.75
Relationships among achieved heart rate, β-blocker dose and long-term outcomes in patients with heart failure with atrial fibrillation. Open Heart (2016) 0.75
Health status in patients with coexistent COPD and heart failure: a validation and comparison between the Clinical COPD Questionnaire and the Minnesota Living with Heart Failure Questionnaire. Int J Chron Obstruct Pulmon Dis (2014) 0.75
Growth Hormone Deficiency Is Associated with Worse Cardiac Function, Physical Performance, and Outcome in Chronic Heart Failure: Insights from the T.O.S.CA. GHD Study. PLoS One (2017) 0.75
Atrial fibrillation in heart failure: drug therapies for rate and rhythm control. Heart Fail Rev (2014) 0.75
Sex and gender considerations in Canadian clinical practice guidelines: a systematic review. CMAJ Open (2017) 0.75
Higher medication doses in heart failure? Can Fam Physician (2017) 0.75
Caregiver Contribution to Heart Failure Self-Care (CACHS). Nurs Open (2015) 0.75
Heart failure guidelines fail. CMAJ (2015) 0.75
Anticoagulation in Heart Failure: a Review. J Atr Fibrillation (2015) 0.75
Effect of contraindicated drugs for heart failure on hospitalization among seniors with heart failure: A nested case-control study. Medicine (Baltimore) (2017) 0.75
The Value of Admission Clinical Data for Diagnosing Heart Failure in Long-term Care. Can Geriatr J (2013) 0.75
Impact of Nitrate Use on Survival in Acute Heart Failure: A Propensity-Matched Analysis. J Am Heart Assoc (2016) 0.75
Anticoagulation in Heart Failure: a Review. J Atr Fibrillation (2015) 0.75
Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure. World J Cardiol (2017) 0.75
Enhancing Knowledge and InterProfessional care for Heart Failure (EKWIP-HF) in long-term care: a pilot study. Pilot Feasibility Stud (2017) 0.75
Approach to advanced heart failure at the end of life. Can Fam Physician (2017) 0.75
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med (2004) 10.02
Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med (2011) 8.93
Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48
Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA (2005) 7.35
Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med (2014) 6.73
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet (2007) 5.06
Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med (2004) 4.72
Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64
Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res (2004) 3.93
A trial of an impedance threshold device in out-of-hospital cardiac arrest. N Engl J Med (2011) 3.76
Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med (2007) 3.74
Aortic diameter, wall stiffness, and wave reflection in systolic hypertension. Hypertension (2007) 3.68
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation (2004) 3.30
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can J Cardiol (2006) 3.20
Pilot study of an Internet patient-physician communication tool for heart failure disease management. J Med Internet Res (2005) 3.12
Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. JAMA (2007) 3.12
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control. Can J Cardiol (2012) 2.96
Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation (2013) 2.90
Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA (2007) 2.89
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol (2008) 2.89
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 2.83
Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure. J Am Coll Cardiol (2012) 2.77
Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS). Circulation (2004) 2.74
Comparison of gas exchange data using the Aquatrainer system and the facemask with Cosmed K4b2 during exercise in healthy subjects. Eur J Appl Physiol (2010) 2.73
Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. J Am Coll Cardiol (2006) 2.68
Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review. Heart Rhythm (2012) 2.65
Angiotensin receptor blockers and risk of myocardial infarction: systematic review. BMJ (2005) 2.57
Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate. Gastroenterology (2013) 2.56
Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review. Circ Heart Fail (2013) 2.50
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J (2011) 2.44
A ciliopathy complex at the transition zone protects the cilia as a privileged membrane domain. Nat Cell Biol (2011) 2.43
Skeletonization of bilateral internal thoracic artery grafts lowers the risk of sternal infection in patients with diabetes. J Thorac Cardiovasc Surg (2003) 2.39
Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation. Am Heart J (2005) 2.39
Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex ≥120 milliseconds. Circulation (2011) 2.36
Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med (2011) 2.34
Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg (2002) 2.31
Mortality and readmission of patients with heart failure, atrial fibrillation, or coronary artery disease undergoing noncardiac surgery: an analysis of 38 047 patients. Circulation (2011) 2.30
Survival after implantable cardioverter-defibrillator implantation in the elderly. Circulation (2013) 2.30
Are stentless valves hemodynamically superior to stented valves? A prospective randomized trial. Ann Thorac Surg (2002) 2.30
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovasc Imaging (2008) 2.24
Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg (2007) 2.24
Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg (2005) 2.24
Survival benefit of primary prevention implantable cardioverter-defibrillator therapy after myocardial infarction: does time to implant matter? A meta-analysis using patient-level data from 4 clinical trials. Heart Rhythm (2013) 2.22
Heart failure clinics and outpatient management: review of the evidence and call for quality assurance. Eur Heart J (2004) 2.20
The mechanism of improved sodium homeostasis of low-dose losartan in preascitic cirrhosis. Hepatology (2002) 2.17
Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the Studies Of Left Ventricular Dysfunction (SOLVD) trials. Circulation (2003) 2.16
Effect of cardiac and noncardiac conditions on survival after defibrillator implantation. J Am Coll Cardiol (2007) 2.15
Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail (2012) 2.13
Cardiac electrophysiological consequences of neuromuscular incapacitating device discharges. J Am Coll Cardiol (2006) 2.11
Identification of an apical Cl(-)/HCO3(-) exchanger in the small intestine. Am J Physiol Gastrointest Liver Physiol (2002) 2.09
Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J (2002) 2.09
Left ventricular reconstruction: Early and late results. J Thorac Cardiovasc Surg (2004) 2.06
Mobile phone-based telemonitoring for heart failure management: a randomized controlled trial. J Med Internet Res (2012) 2.06
Quality of life and exercise performance in patients in sinus rhythm versus persistent atrial fibrillation: a Veterans Affairs Cooperative Studies Program Substudy. J Am Coll Cardiol (2006) 2.06
Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis. J Thorac Cardiovasc Surg (2004) 2.03
Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis. Anesthesiology (2015) 2.02
Highly sensitized patients in cardiac transplantation: early outcomes from the Canadian Prioritized Organ Sharing Program. J Heart Lung Transplant (2012) 2.01
Transmural action potential and ionic current remodeling in ventricles of failing canine hearts. Am J Physiol Heart Circ Physiol (2002) 2.00
Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation (2008) 1.98
Rapid induction of therapeutic hypothermia using convective-immersion surface cooling: safety, efficacy and outcomes. Resuscitation (2010) 1.93
A population-based description of atrial fibrillation in the emergency department, 2002 to 2010. Ann Emerg Med (2013) 1.91
Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation). J Am Coll Cardiol (2011) 1.91
Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation (2012) 1.91
Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial. Circulation (2006) 1.86
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86
Augmentation index and central aortic stiffness in middle-aged to elderly individuals. Am J Hypertens (2007) 1.85
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85
Grapefruit-medication interactions: forbidden fruit or avoidable consequences? CMAJ (2012) 1.84
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. Eur Heart J (2012) 1.82
Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database. Ann Intern Med (2012) 1.80
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations. Heart Rhythm (2008) 1.79
The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol (2011) 1.78